Osteoblast Ca2+ channels play a fundamental role in controlling intrac
ellular and systemic Ca2+ homeostasis. A reverse transcription-polymer
ase chain reaction strategy was used to determine the molecular identi
ty of voltage-sensitive calcium channels present in ROS 17/2.8 osteosa
rcoma cells. The amino acid sequences encoded by the two resultant PCR
products matched the alpha 1(C-a) and the alpha 1(C-d) isoforms. The
ability of 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3) and structural a
nalogs to modulate expression of voltage-sensitive calcium channel mRN
A transcripts was then investigated. ROS 17/2.8 cells were cultured fo
r 48 h in the presence of either 1,25(OH)(2)D-3, 1,24-dihydroxy-22-ene
-24-cyclopropyl D-3 (analog BT) or 25-hydroxy-16-ene-23-yne-D-3 (analo
g AT), and the levels of mRNA encoding alpha(1C) were quantitated usin
g a competitive reverse transcription-polymerase chain reaction assay.
We found that 1,25(OH)(2)D-3 and analog BT reduced steady state level
s of alpha(1C) mRNA. Conversely, the Ca2+-mobilizing analog AT did not
alter steady state levels of voltage-sensitive calcium channel mRNA.
Since analog BT, but not analog AT, binds and transcriptionally activa
tes the nuclear receptor for 1,25(OH)(2)D-3, these findings suggest th
at the down-regulation of voltage-sensitive calcium channel mRNA level
s may involve the nuclear receptor.